Nicolino Ruperto Selected Research

Juvenile Arthritis (Juvenile Idiopathic Arthritis)

1/2022	Anakinra in Patients With Systemic Juvenile Idiopathic Arthritis: Long-term Safety From the Pharmachild Registry.
1/2022	Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis.
1/2022	Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use.
1/2022	Tofacitinib for juvenile idiopathic arthritis - Authors' reply.
11/2021	Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
10/2021	Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis.
10/2021	Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis.
5/2021	Publisher Correction: Biological classification of childhood arthritis: roadmap to a molecular nomenclature.
1/2021	Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial.
1/2021	Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolino Ruperto Research Topics

Disease

62	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 07/2004
18	Arthritis (Polyarthritis) 01/2022 - 08/2003
11	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 09/2004
11	Dermatomyositis (Dermatopolymyositis) 05/2019 - 09/2004
10	Infections 11/2021 - 12/2012
8	Fever (Fevers) 12/2020 - 11/2004
7	Body Weight (Weight, Body) 01/2021 - 02/2005
7	Myositis (Idiopathic Inflammatory Myopathies) 01/2018 - 09/2005
6	Pain (Aches) 01/2022 - 12/2007
6	Inflammation (Inflammations) 11/2018 - 12/2007
5	Psoriatic Arthritis 12/2020 - 01/2011
3	Cryopyrin-Associated Periodic Syndromes 01/2022 - 05/2013
3	Uveitis 01/2022 - 08/2003
3	Macrophage Activation Syndrome 01/2022 - 12/2012
3	Mevalonate Kinase Deficiency 01/2022 - 05/2013
3	Necrosis 01/2022 - 08/2008
3	Familial Mediterranean Fever (Periodic Disease) 01/2021 - 05/2013
3	Rheumatic Diseases (Rheumatism) 12/2020 - 01/2008
2	Neoplasms (Cancer) 01/2022 - 06/2014
2	Negative rheumatoid factor polyarthritis 11/2021 - 01/2011
2	Rheumatoid Arthritis 10/2021 - 06/2015
2	Abdominal Pain (Pain, Abdominal) 01/2021 - 05/2010
2	Proteinuria 01/2021 - 05/2010
2	Neutropenia 01/2019 - 12/2012
2	Lymphadenitis (Adenitis) 04/2018 - 05/2013
2	Injection Site Reaction 01/2018 - 02/2012
2	Splenomegaly 10/2017 - 11/2004
2	Pharyngitis (Sore Throat) 05/2013 - 09/2011
2	Hypertriglyceridemia 04/2011 - 11/2009
2	Hyperferritinemia 04/2011 - 11/2009
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Adult-Onset Still's Disease 11/2020
1	Tetanus 02/2020
1	Diphtheria 02/2020
1	Spondylitis 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2018
1	Aphthous Stomatitis (Aphthous Ulcer) 04/2018
1	Herpes Zoster 11/2016
1	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 11/2016
1	Pericarditis 11/2016

Drug/Important Bio-Agent (IBA)

22	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 07/2004
9	tocilizumab (atlizumab)FDA Link 10/2021 - 12/2012
8	Abatacept (Orencia)FDA Link 01/2021 - 08/2008
7	Etanercept (Enbrel)FDA Link 01/2022 - 02/2013
7	canakinumab FDA Link 01/2021 - 02/2012
7	C-Reactive ProteinIBA 10/2020 - 11/2004
6	Biological ProductsIBA 05/2021 - 06/2014
6	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2020 - 08/2003
5	GlucocorticoidsIBA 01/2021 - 12/2012
5	Antirheumatic Agents (DMARD)IBA 10/2020 - 08/2008
5	Prednisone (Sone)FDA LinkGeneric 09/2019 - 02/2016
4	ametantrone (HAQ)IBA 01/2021 - 12/2007
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2019 - 02/2016
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 06/2014
3	tofacitinibIBA 01/2022 - 12/2017
3	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2022 - 05/2010
3	Rheumatoid FactorIBA 11/2021 - 01/2019
3	Colchicine FDA LinkGeneric 01/2021 - 11/2016
3	Adalimumab (Humira)FDA Link 10/2020 - 08/2008
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2019 - 08/2008
3	Antinuclear AntibodiesIBA 01/2019 - 08/2003
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 12/2012
3	Infliximab (Remicade)FDA Link 09/2010 - 09/2007
2	Interleukin-1 (Interleukin 1)IBA 01/2022 - 12/2012
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2022 - 11/2016
2	golimumab FDA Link 10/2021 - 01/2018
2	belimumabIBA 01/2021 - 10/2020
2	amsonic acid (DAS)IBA 11/2020 - 11/2011
2	Ferritins (Ferritin)IBA 10/2019 - 10/2014
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2019 - 11/2009
2	Fibrinogen (Factor I)FDA Link 10/2019 - 10/2017
2	Rituximab (Mabthera)FDA Link 05/2017 - 01/2017
2	Transaminases (Aminotransferases)IBA 11/2016 - 12/2012
2	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 05/2013 - 11/2011
1	N-phthaloylglutamic acidIBA 01/2022
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2021
1	Diphtheria-Tetanus VaccineIBA 02/2020
1	VaccinesIBA 02/2020
1	Tumor Necrosis Factor InhibitorsIBA 09/2019
1	SteroidsIBA 09/2019
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2019
1	CreatinineIBA 01/2019
1	Synthetic DrugsIBA 12/2018
1	AutoantibodiesIBA 11/2018
1	SolutionsIBA 12/2017
1	TabletsIBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 10/2017
1	InterleukinsIBA 11/2016
1	Pharmaceutical PreparationsIBA 02/2016
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 06/2015
1	Collagen Type I (Type I Collagen)IBA 03/2015
1	Growth Hormone (Somatotropin)IBA 03/2015
1	OsteocalcinIBA 03/2015

Therapy/Procedure

26	Therapeutics 01/2019 - 08/2003
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2011
2	Injections 01/2018 - 08/2003
1	Drug Tapering 12/2020
1	Time-to-Treatment 02/2016